Compile Data Set for Download or QSAR
maximum 50k data
Found 207 with Last Name = 'guney' and Initial = 't'
TargetAnthranilate--CoA ligase(Pseudomonas aeruginosa (Gram- Bacteria))
East Carolina University

LigandPNGBDBM205460(Salicyl-AMS (3))
Affinity DataKi:  88nMpH: 8.0Assay Description:Reactions were performed at 37 °C in a 0.5 mL volume in a Varian Cary 100 UV-visible spectrophotometer with Cary WinUV software. Reaction mixtures co...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAnthranilate--CoA ligase(Pseudomonas aeruginosa (Gram- Bacteria))
East Carolina University

LigandPNGBDBM205461(Salicyl-AMSN (4))
Affinity DataKi:  109nMpH: 8.0Assay Description:Reactions were performed at 37 °C in a 0.5 mL volume in a Varian Cary 100 UV-visible spectrophotometer with Cary WinUV software. Reaction mixtures co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetAnthranilate--CoA ligase(Pseudomonas aeruginosa (Gram- Bacteria))
East Carolina University

LigandPNGBDBM205459(Anthranilyl-AMSN (2))
Affinity DataKi:  170nMpH: 8.0Assay Description:Reactions were performed at 37 °C in a 0.5 mL volume in a Varian Cary 100 UV-visible spectrophotometer with Cary WinUV software. Reaction mixtures co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetAnthranilate--CoA ligase(Pseudomonas aeruginosa (Gram- Bacteria))
East Carolina University

LigandPNGBDBM205458(Anthranilyl-AMS (1))
Affinity DataKi:  205nMpH: 8.0Assay Description:Reactions were performed at 37 °C in a 0.5 mL volume in a Varian Cary 100 UV-visible spectrophotometer with Cary WinUV software. Reaction mixtures co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetAnthranilate--CoA ligase(Pseudomonas aeruginosa (Gram- Bacteria))
East Carolina University

LigandPNGBDBM205462(Benzoyl-AMS (5))
Affinity DataKi:  420nMpH: 8.0Assay Description:Reactions were performed at 37 °C in a 0.5 mL volume in a Varian Cary 100 UV-visible spectrophotometer with Cary WinUV software. Reaction mixtures co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetAnthranilate--CoA ligase(Pseudomonas aeruginosa (Gram- Bacteria))
East Carolina University

LigandPNGBDBM50413189(CHEMBL457531 | Salicyl-AVSN (7))
Affinity DataKi:  1.54E+4nMpH: 8.0Assay Description:Reactions were performed at 37 °C in a 0.5 mL volume in a Varian Cary 100 UV-visible spectrophotometer with Cary WinUV software. Reaction mixtures co...More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetAnthranilate--CoA ligase(Pseudomonas aeruginosa (Gram- Bacteria))
East Carolina University

LigandPNGBDBM205463(Anthranilyl-AVSN (6))
Affinity DataKi:  3.63E+4nMpH: 8.0Assay Description:Reactions were performed at 37 °C in a 0.5 mL volume in a Varian Cary 100 UV-visible spectrophotometer with Cary WinUV software. Reaction mixtures co...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629513(US20230339981, Example 201)
Affinity DataIC50:  0.0200nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629510(US20230339981, Example 198)
Affinity DataIC50:  0.0200nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629518(US20230339981, Example 206)
Affinity DataIC50:  0.0400nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629509(US20230339981, Example 197)
Affinity DataIC50:  0.0400nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629381(US20230339981, Example 68)
Affinity DataIC50:  0.0500nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629505(US20230339981, Example 193)
Affinity DataIC50:  0.0500nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629512(US20230339981, Example 200)
Affinity DataIC50:  0.0500nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629519(US20230339981, Example 207)
Affinity DataIC50:  0.0600nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629387(US20230339981, Example 75)
Affinity DataIC50:  0.0600nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629517(US20230339981, Example 205)
Affinity DataIC50:  0.0600nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629511(US20230339981, Example 199)
Affinity DataIC50:  0.0700nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629507(US20230339981, Example 195)
Affinity DataIC50:  0.0700nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629380(US20230339981, Example 67)
Affinity DataIC50:  0.0800nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629520(US20230339981, Example 208)
Affinity DataIC50:  0.0900nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629340(US20230339981, Example 22)
Affinity DataIC50:  0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629368(US20230339981, Example 52)
Affinity DataIC50:  0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629369(US20230339981, Example 53 | US20240025919, Compoun...)
Affinity DataIC50:  0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629377(US20230339981, Example 64)
Affinity DataIC50:  0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629382(US20230339981, Example 69)
Affinity DataIC50:  0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629383(US20230339981, Example 70)
Affinity DataIC50:  0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629388(US20230339981, Example 76)
Affinity DataIC50:  0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629392(US20230339981, Example 80 | US20230339981, Example...)
Affinity DataIC50:  0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629406(US20230339981, Example 94)
Affinity DataIC50:  0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629421(US20230339981, Example 109)
Affinity DataIC50:  0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629427(US20230339981, Example 115)
Affinity DataIC50:  0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629429(US20230339981, Example 117)
Affinity DataIC50:  0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629434(US20230339981, Example 122)
Affinity DataIC50: <0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629435(US20230339981, Example 123)
Affinity DataIC50: <0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629445(US20230339981, Example 133)
Affinity DataIC50:  0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629451(US20230339981, Example 139)
Affinity DataIC50:  0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629422(US20230339981, Example 110 | US20230339981, Exampl...)
Affinity DataIC50: <0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629460(US20230339981, Example 148)
Affinity DataIC50:  0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629461(US20230339981, Example 149)
Affinity DataIC50: <0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629463(US20230339981, Example 151 | US20230339981, Exampl...)
Affinity DataIC50:  0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629464(US20230339981, Example 152)
Affinity DataIC50:  0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629466(US20230339981, Example 154)
Affinity DataIC50:  0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629467(US20230339981, Example 155)
Affinity DataIC50:  0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629475(US20230339981, Example 163)
Affinity DataIC50:  0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629477(US20230339981, Example 165)
Affinity DataIC50: <0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629479(US20230339981, Example 167)
Affinity DataIC50: <0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629483(US20230339981, Example 171)
Affinity DataIC50: <0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629485(US20230339981, Example 173)
Affinity DataIC50: <0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetGTPase KRas [G12D](Homo sapiens (Human))
Gilead Sciences

US Patent
LigandPNGBDBM629488(US20230339981, Example 176)
Affinity DataIC50:  0.100nMAssay Description:Compounds were tested for binding to GDP-loaded KRAS G12D in a 384-well assay format using a TR-FRET probe displacement assay in buffer consisting of...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 207 total ) | Next | Last >>
Jump to: